← Back to Clinical Trials
Recruiting NCT07435831

NCT07435831 Kimchi and Gut Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07435831
Status Recruiting
Phase
Sponsor University of California, Davis
Condition Healthy Adult Participants
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-30
Primary Completion 2027-01-30

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
60 grams per day of intervention food60 grams per day of intervention food

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-03-30 with a primary completion date of 2027-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to learn about the effects of eating kimchi on the gut health of healthy adults in the USA. The investigators will be researching the changes in the gut microbiome, biomarkers of gut health and cardiometabolic health after consuming fermented and unfermented cabbage. The main questions it aims to answer are: Does eating kimchi (fermented cabbage) result in enrichment of lactic acid bacteria in the stools of participants? Does eating kimchi result in metabolic changes in the gut microbiome, biomarkers of gut and cardiometabolic health of participants? Researchers will compare a group of participants eating fermented cabbage (kimchi) daily to a group of participants eating non-fermented cabbage daily. Participants will: Eat kimchi or cabbage daily for 3 weeks. Visit the study site for brief visits up to 5 times. Have blood drawn and provide a fecal sample 2 times - at beginning and end of the 3 week study. Keep occasional records of food intake and questionnaires about any gastrointestinal symptoms that participants may have.

Eligibility Criteria

Inclusion Criteria: * BMI of 25-30 kg/m2 * No or occasional consumption of kimchi (3 or fewer times per week) * Willing to eat study food every day for 3 weeks * Willing to participate in study protocols Exclusion Criteria: * Allergy to cabbage and /or cruciferous family vegetables * Allergy to kimchi ingredients such as shellfish and fish sauce * Daily consumption of kimchi * Diagnosed digestive issues such as irritable bowel syndrome (IBS) or gastrointestinal inflammatory bowel disease (IBD) or conditions such as Crohn's disease * Previous bowel surgery that disrupts the digestive flow, motility or gastric emptying process * Antibiotics used in the 2 months prior to enrollment * Unwillingness to discontinue probiotics during study and washout period * Active diagnosis and/or treatment for cancer

Frequently Asked Questions

Who can join the NCT07435831 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, up to 70 Years, studying Healthy Adult Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07435831 currently recruiting?

Yes, NCT07435831 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of California, Davis to inquire about joining.

Where is the NCT07435831 trial being conducted?

This trial is being conducted at Davis, United States, Davis, United States.

Who is sponsoring the NCT07435831 clinical trial?

NCT07435831 is sponsored by University of California, Davis. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology